Elizabeth L. Strevel

Continental Divide? The Attitudes of US and Canadian Oncologists on the Costs, Cost-Effectiveness, and Health Policies Associated With New Cancer Drugs

Scott R. Berry, Chaim M. Bell, Peter A. Ubel et al. · Journal of Clinical Oncology · 2010 · 77 citations · Full text

Public Affairs, Health Policy, Oncology +17

Severe and protracted hypoglycaemia associated with co-trimoxazole use

Elizabeth L. Strevel, Ayelet Kuper, Wayne L. Gold · The Lancet Infectious Diseases · 2006 · 52 citations

Medicine, Pharmacology, Pharmacotherapy +5

Randomized phase II study of modified FOLFOX-6 in combination with ramucirumab or icrucumab as second-line therapy in patients with metastatic colorectal cancer after disease progression on first-line irinotecan-based therapy

Miranda A. Moore, Sanjeev Gill, Timothy R. Asmis et al. · Annals of Oncology · 2016 · 37 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

The impact of an educational DVD on cancer patients considering participation in a phase I clinical trial

Elizabeth L. Strevel, Colin Newman, Gregory R. Pond et al. · Supportive Care in Cancer · 2006 · 34 citations

Medicine, Medical Education, Oncology +9

A Pooled Exploratory Analysis of the Effect of Tumor Size and KRAS Mutations on Survival Benefit From Adjuvant Platinum-Based Chemotherapy in Node-Negative Non–Small Cell Lung Cancer

Sinéad Cuffe, Abderrahmane Bourredjem, Stephen L. Graziano et al. · Journal of Thoracic Oncology · 2012 · 31 citations · Full text

Medicine, Oncology, Pharmacology +16